These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 28117810)

  • 1. Generation of Murine Monoclonal Antibodies by Hybridoma Technology.
    Holzlöhner P; Hanack K
    J Vis Exp; 2017 Jan; (119):. PubMed ID: 28117810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen-based immunofluorescence analysis of B-cell targeting: advanced technology for the generation of novel monoclonal antibodies with high efficiency and selectivity.
    Tomita M; Fukuda T; Ozu A; Kimura K; Tsong TY; Yoshimura T
    Hybridoma (Larchmt); 2006 Oct; 25(5):283-92. PubMed ID: 17044784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies and Selection of Monoclonal Antibodies.
    Hanack K; Messerschmidt K; Listek M
    Adv Exp Med Biol; 2016; 917():11-22. PubMed ID: 27236550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of monoclonal antibodies.
    Yokoyama WM; Christensen M; Santos GD; Miller D; Ho J; Wu T; Dziegelewski M; Neethling FA
    Curr Protoc Immunol; 2013 Oct; 102():2.5.1-2.5.29. PubMed ID: 24510488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybridoma Technology.
    Hnasko RM; Stanker LH
    Methods Mol Biol; 2015; 1318():15-28. PubMed ID: 26160560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of monoclonal antibodies.
    Yokoyama WM
    Curr Protoc Cell Biol; 2001 May; Chapter 16():Unit 16.1. PubMed ID: 18228333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel immunization protocol and ELISA screening methods used to obtain and characterize monoclonal antibodies specific for human light chain variable-region subgroups.
    Abe M; Goto T; Wolfenbarger D; Weiss DT; Solomon A
    Hybridoma; 1993 Aug; 12(4):475-83. PubMed ID: 8244419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hybridoma technologies for antibody production.
    Tomita M; Tsumoto K
    Immunotherapy; 2011 Mar; 3(3):371-80. PubMed ID: 21395379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and characterization of monoclonal antibodies against human CD20 in Balb/c mice.
    Sepehr KS; Baradaran B; Majidi J; Abdolalizadeh J; Aghebati L; Shahneh FZ
    Hum Antibodies; 2012; 21(3-4):57-64. PubMed ID: 23549022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of monoclonal antibodies.
    Yokoyama WM; Christensen M; Santos GD; Miller D
    Curr Protoc Immunol; 2006 Sep; Chapter 2():2.5.1-2.5.25. PubMed ID: 18432969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A monoclonal antibody specific for Δ12-prostaglandin J2 and its utilization in the immunological assay in cell culture system of adipocytes.
    Syeda PK; Hossain MS; Chowdhury AA; Rahman MS; Khan F; Nishimura K; Jisaka M; Nagaya T; Shono F; Yokota K
    Hybridoma (Larchmt); 2012 Oct; 31(5):364-71. PubMed ID: 23098304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid generation of monoclonal antibody-secreting hybridomas against African horse sickness virus by in vitro immunization and the fusion/cloning technique.
    Stäuber N; Kihm U; McCullough KC
    J Immunol Methods; 1993 May; 161(2):157-68. PubMed ID: 8505546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody engineering, a strategy for the development of monoclonal antibodies.
    Schönherr OT; Houwink EH
    Antonie Van Leeuwenhoek; 1984; 50(5-6):597-623. PubMed ID: 6099095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of monoclonal antibodies.
    Yokoyama WM
    Curr Protoc Cytom; 2006 Aug; Appendix 3():Appendix 3J. PubMed ID: 18770829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and characterization of monoclonal antibodies against human IgA in Balb/c mice.
    Ezzatifar F; Majidi J; Baradaran B; Maleki LA; Abdolalizadeh J; Yousefi M
    Hum Antibodies; 2014; 23(1-2):7-12. PubMed ID: 25812697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput homogeneous immunoassay readily identifies monoclonal antibody to serovariant clostridial neurotoxins.
    Corbett CR; Elias MD; Simpson LL; Yuan XY; Cassan RR; Ballegeer E; Kabani A; Plummer FA; Berry JD
    J Immunol Methods; 2007 Dec; 328(1-2):128-38. PubMed ID: 17936779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybridoma technology.
    Price PJ
    Ric Clin Lab; 1984; 14(3):277-86. PubMed ID: 6395287
    [No Abstract]   [Full Text] [Related]  

  • 19. B-cell receptor-based multitargeting method for simultaneous production of novel multiple monoclonal antibodies.
    Obata H; Tsumoto K; Tomita M
    J Biosci Bioeng; 2019 Nov; 128(5):578-584. PubMed ID: 31147218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of human monoclonal antibodies to B lymphocyte cell surface antigens by in vitro immunization and human-human hybridoma technology.
    Power DA; Gerkis V; d'Apice AJ
    Hum Antibodies Hybridomas; 1990; 1(1):34-41. PubMed ID: 2103351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.